Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liquid Biopsies beyond Mutation Calling: Genomic and Epigenomic Features of Cell-Free DNA in Cancer
Arlou Kristina Angeles, Florian Janke, Simone Bauer, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5615-5615
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance
Pavel Stejskal, Hani Goodarzi, Josef Srovnal, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 112
Bridging biological cfDNA features and machine learning approaches
Tina Moser, Stefan Kühberger, Isaac Lazzeri, et al.
Trends in Genetics (2023) Vol. 39, Iss. 4, pp. 285-307
Open Access | Times Cited: 56
Diagnostic value of liquid biopsy in the era of precision medicine: 10 years of clinical evidence in cancer
Vincenza Caputo, Fortunato Ciardiello, Carminia M. Della Corte, et al.
Exploration of Targeted Anti-tumor Therapy (2023), pp. 102-138
Open Access | Times Cited: 36
Epigenetic Biomarkers Driven by Environmental Toxins Associated with Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the United States: A Systematic Review
Melanie Engstrom Newell, Anumitha Aravindan, Ayesha Babbrah, et al.
Toxics (2025) Vol. 13, Iss. 2, pp. 114-114
Open Access
Understanding the Landscape of Multi-Cancer Detection Tests: The Current Data and Clinical Considerations
Cody E. Cotner, Elizabeth O’Donnell
Life (2024) Vol. 14, Iss. 7, pp. 896-896
Open Access | Times Cited: 3
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer
Caterina Gianni, Michela Palleschi, Filippo Merloni, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14197-14197
Open Access | Times Cited: 18
Innovation in Non-Invasive Diagnosis and Disease Monitoring for Meningiomas
B. Korte, Dimitrios Mathios
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4195-4195
Open Access | Times Cited: 3
Towards effectiveness of cell free DNA based liquid biopsy in head and neck squamous cell carcinoma
Ewelina Kowal-Wiśniewska, Katarzyna Jaśkiewicz, Anna Bartochowska, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Concept and feasibility of the Augsburg Longitudinal Plasma Study (ALPS) – a prospective trial for comprehensive liquid biopsy-based longitudinal monitoring of solid cancer patients
Sebastian Sommer, Maximilian Schmutz, Kathrin Hildebrand, et al.
Journal of Laboratory Medicine (2024) Vol. 48, Iss. 3, pp. 107-119
Open Access | Times Cited: 2
The Role of DNA Methylation and DNA Methyltransferases in Cancer
Daniel J. Weisenberger, Ranjani Lakshminarasimhan, Gangning Liang
Advances in experimental medicine and biology (2022), pp. 317-348
Closed Access | Times Cited: 14
Experimental and Bioinformatic Approaches to Studying DNA Methylation in Cancer
Angelika Merkel, Manel Esteller
Cancers (2022) Vol. 14, Iss. 2, pp. 349-349
Open Access | Times Cited: 13
Overview of the role of liquid biopsy in cancer management
Tarek Assi, Rita Khoury, Rebecca Ibrahim, et al.
Translational Oncology (2023) Vol. 34, pp. 101702-101702
Open Access | Times Cited: 6
Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitors
Hannah Schindler, Fabienne Lusky, Lea Daniello, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
The rising tide of cell-free DNA profiling: from snapshot to temporal genome analysis
Abel J. Bronkhorst, Vida Ungerer, Angela Oberhofer, et al.
Journal of Laboratory Medicine (2022) Vol. 46, Iss. 4, pp. 207-224
Open Access | Times Cited: 10
Is ctDNA ready to outpace imaging in monitoring early and advanced breast cancer?
Lorenzo Foffano, Riccardo Vida, Alberto Piacentini, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 8, pp. 679-691
Closed Access | Times Cited: 1
Positron Emission Tomography-Based Immunoimaging for Cancer Patient Stratification: Toward a More Holistic Approach
Antonia Dimitrakopoulou‐Strauss, Christos Sachpekidis, Jessica C. Hassel, et al.
Cancer Biotherapy and Radiopharmaceuticals (2023) Vol. 38, Iss. 4, pp. 225-231
Closed Access | Times Cited: 4
Monitoring EGFR-lung cancer evolution: a possible beginning of a “methylation era” in TKI resistance prediction
Federico Pio Fabrizio, Angelo Sparaneo, Lucia Anna Muscarella
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Testing the generalizability of cfDNA fragmentomic features across different studies for cancer early detection
Shu Su, Yulong Xuan, Xiaojun Fan, et al.
Genomics (2023) Vol. 115, Iss. 4, pp. 110662-110662
Open Access | Times Cited: 3
Liquid biopsies come of age in lung cancer
Petros Christopoulos
Translational Lung Cancer Research (2022) Vol. 11, Iss. 5, pp. 706-710
Open Access | Times Cited: 5
Brief Report: A Blood-Based MicroRNA Complementary Diagnostic Predicts Immunotherapy Efficacy in Advanced-Stage NSCLC With High Programmed Death-Ligand 1 Expression
Timothy Rajakumar, Rastislav Horos, Paul Kittner, et al.
JTO Clinical and Research Reports (2022) Vol. 3, Iss. 8, pp. 100369-100369
Open Access | Times Cited: 5
Identification of Somatic Mutations in Plasma Cell-Free DNA from Patients with Metastatic Oral Squamous Cell Carcinoma
Li-Han Lin, Kuo‐Wei Chang, Hui‐Wen Cheng, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10408-10408
Open Access | Times Cited: 2
Comprehensive Analysis Reveals Deoxyribonuclease 1 as a Potential Prognostic and Diagnostic Biomarker in Human Cancers
Loai F Eletr, Sahar H Ibnouf, Tanzeel A Salih, et al.
Cureus (2024)
Open Access
Prediction of Transcription Factor Binding Sites on Cell-Free DNA Based on Deep Learning
Ting Qi, Ying Zhou, Yuqi Sheng, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 10, pp. 4002-4008
Closed Access
Machine Learning and Deep Learning for Early Detection of Genetic Mutations in Various Cancers
Mubarak Shah
(2024), pp. 1-12
Closed Access
The DKTK EXLIQUID consortium – exploiting liquid biopsies to advance cancer precision medicine for molecular tumor board patients
Matthias Mack, Julian Broche, Stephen George, et al.
Journal of Laboratory Medicine (2022) Vol. 46, Iss. 4, pp. 321-330
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top